We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth (UNH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Read MoreHide Full Article
For the quarter ended March 2023, UnitedHealth Group (UNH - Free Report) reported revenue of $91.93 billion, up 14.7% over the same period last year. EPS came in at $6.26, compared to $5.49 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $89.33 billion, representing a surprise of +2.92%. The company delivered an EPS surprise of +0.32%, with the consensus EPS estimate being $6.24.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Operating Statistics- Medical Care Ratio: 82.2% compared to the 82.46% average estimate based on six analysts.
Revenues- Optum Health: $23 billion compared to the $21.58 billion average estimate based on 10 analysts.
Revenues- Services: $8.08 billion compared to the $7.75 billion average estimate based on eight analysts. The reported number represents a change of +26.8% year over year.
Revenues- Investment and other income: $798 million versus $572.43 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +117.4% change.
Revenues- Products: $10.27 billion versus the eight-analyst average estimate of $9.74 billion. The reported number represents a year-over-year change of +9.9%.
Revenues- Premiums: $72.79 billion versus the eight-analyst average estimate of $71.38 billion. The reported number represents a year-over-year change of +13.6%.
Revenues- Total Optum: $54.06 billion versus $51.14 billion estimated by five analysts on average.
Revenues- Optum Rx: $27.42 billion versus $25.71 billion estimated by five analysts on average.
Revenues- Optum Insight: $4.50 billion versus $4.51 billion estimated by five analysts on average.
Revenues- UnitedHealthcare: $70.47 billion versus $69.28 billion estimated by five analysts on average.
Revenues- Optum Eliminations: -$859 million versus the four-analyst average estimate of -$845.30 million.
Revenues- United Healthcare - Employer & Individual: $18.71 billion versus $17.03 billion estimated by three analysts on average.
Shares of UnitedHealth have returned +11.5% over the past month versus the Zacks S&P 500 composite's +7.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth (UNH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2023, UnitedHealth Group (UNH - Free Report) reported revenue of $91.93 billion, up 14.7% over the same period last year. EPS came in at $6.26, compared to $5.49 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $89.33 billion, representing a surprise of +2.92%. The company delivered an EPS surprise of +0.32%, with the consensus EPS estimate being $6.24.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Operating Statistics- Medical Care Ratio: 82.2% compared to the 82.46% average estimate based on six analysts.
- Revenues- Optum Health: $23 billion compared to the $21.58 billion average estimate based on 10 analysts.
- Revenues- Services: $8.08 billion compared to the $7.75 billion average estimate based on eight analysts. The reported number represents a change of +26.8% year over year.
- Revenues- Investment and other income: $798 million versus $572.43 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +117.4% change.
- Revenues- Products: $10.27 billion versus the eight-analyst average estimate of $9.74 billion. The reported number represents a year-over-year change of +9.9%.
- Revenues- Premiums: $72.79 billion versus the eight-analyst average estimate of $71.38 billion. The reported number represents a year-over-year change of +13.6%.
- Revenues- Total Optum: $54.06 billion versus $51.14 billion estimated by five analysts on average.
- Revenues- Optum Rx: $27.42 billion versus $25.71 billion estimated by five analysts on average.
- Revenues- Optum Insight: $4.50 billion versus $4.51 billion estimated by five analysts on average.
- Revenues- UnitedHealthcare: $70.47 billion versus $69.28 billion estimated by five analysts on average.
- Revenues- Optum Eliminations: -$859 million versus the four-analyst average estimate of -$845.30 million.
- Revenues- United Healthcare - Employer & Individual: $18.71 billion versus $17.03 billion estimated by three analysts on average.
View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned +11.5% over the past month versus the Zacks S&P 500 composite's +7.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.